Koers Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Aandelen
PNAX
IL0011043630
Bedrijfsondersteunende diensten
Omzet 2022 | 39,42 mln. 10,35 mln. 9,68 mln. | Omzet 2023 | 19,59 mln. 5,15 mln. 4,81 mln. | Marktkapitalisatie | 22,44 mln. 5,89 mln. 5,51 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -43 mln. -11,29 mln. -10,56 mln. | Nettowinst (verlies) 2023 | -13 mln. -3,41 mln. -3,19 mln. | EV/omzet 2022 | 1,63 x |
Nettoschuld 2022 | 36,12 mln. 9,49 mln. 8,87 mln. | Nettoschuld 2023 | 36,1 mln. 9,48 mln. 8,87 mln. | EV/omzet 2023 | 2,99 x |
K/w-verhouding 2022 |
-0,65
x | K/w-verhouding 2023 |
-168
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 37,69% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01-10-19 |
Assi Rotbart
CHM | Chairman | 49 | 01-10-19 |
Director of Finance/CFO | 66 | 28-12-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 53 | 29-12-21 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21-07-16 |
Michal Sapir
BRD | Director/Board Member | 66 | 17-03-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,55% | 67,6 mld. | |
+11,64% | 18,21 mld. | |
+21,03% | 13,41 mld. | |
+9,40% | 13,37 mld. | |
+16,53% | 9,94 mld. | |
-32,90% | 5,74 mld. | |
-10,98% | 5,57 mld. | |
-4,09% | 4,91 mld. | |
-4,83% | 4,87 mld. |